GC Therapeutics Funding: $75M Raised, Series A (2024)
GC Therapeutics is based in Cambridge, Massachusetts. It has raised $75M in total funding. Latest round: Series A.
GC Therapeutics funding overview
GC Therapeutics is based in Cambridge, Massachusetts. GC Therapeutics has raised $75M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in September 2024. The round record for GC Therapeutics runs through 2024; nothing later has been disclosed. Investors on record include Cormorant Asset Management, Mubadala Capital, a16z Bio + Health, Medical Excellence Capital, Cercano Management, Pear VC and 1 others. 7 distinct backers are named across the disclosed rounds.
GC Therapeutics at a glance
Total raised
$75M
Latest round
Series A
Latest round date
September 2024
Headquarters
Cambridge, Massachusetts
Notable investors
Cormorant Asset Management, Mubadala Capital, a16z Bio + Health, Medical Excellence Capital, Cercano Management, Pear VC, Andreessen Horowitz
Frequently asked about GC Therapeutics funding
How much has GC Therapeutics raised?
GC Therapeutics has raised $75M in total disclosed funding across the rounds on record.
Who has invested in GC Therapeutics?
Cormorant Asset Management, Mubadala Capital, a16z Bio + Health, Medical Excellence Capital, Cercano Management, Pear VC are named among the investors backing GC Therapeutics.
What was the latest GC Therapeutics funding round?
The most recent disclosed round is a Series A, announced in September 2024.
Where is GC Therapeutics based?
GC Therapeutics is based in Cambridge, Massachusetts.
When did GC Therapeutics last raise?
The last disclosed GC Therapeutics round closed in September 2024 at Series A.
Round data for GC Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Cambridge and backer lists below.
